Many important associations have been found between the newly discovered myokine irisin and measures of metabolic disease. However, not much is known regarding the role of irisin in human disease. Two recent reports now identify novel metabolic associations for this molecule in humans.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
Scientific Reports Open Access 23 April 2019
-
ROCK1 reduces mitochondrial content and irisin production in muscle suppressing adipocyte browning and impairing insulin sensitivity
Scientific Reports Open Access 14 July 2016
-
Swimming exercise increases serum irisin level and reduces body fat mass in high-fat-diet fed Wistar rats
Lipids in Health and Disease Open Access 13 May 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Boström, P. et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463–468 (2012).
Park, K. H. et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J. Clin. Endocrinol. Metab. http://dx.doi.org/10.1210/jc.2013-2373.
Vamvini, M. T. et al. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. Eur. J. Endocrinol. 169, 829–834 (2013).
Zhang, H. J. et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J. Hepatol. 59, 557–562 (2013).
Raschke, S. et al. Evidence against a beneficial effect of irisin in humans. PLoS ONE 8, e73680 (2013).
Erickson, H. P. Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocyte 2, 289–293 (2013).
Huh, J. Y. et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61, 1725–1738 (2012).
Ivanov, I. P., Firth, A. E., Michel, A. M., Atkins, J. F. & Baranov, P. V. Identification of evolutionarily conserved non-AUG-initiated N-terminal extensions in human coding sequences. Nucleic Acids Res. 39, 4220–4234 (2011).
Moreno-Navarrete, J. M. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J. Clin. Endocrinol. Metab. 98, E769–E778 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Boström, P., Fernández-Real, J. Irisin, the metabolic syndrome and follistatin in humans. Nat Rev Endocrinol 10, 11–12 (2014). https://doi.org/10.1038/nrendo.2013.230
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2013.230
This article is cited by
-
Impact of adipokines and myokines on fat browning
Journal of Physiology and Biochemistry (2020)
-
The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
Scientific Reports (2019)
-
Swimming exercise increases serum irisin level and reduces body fat mass in high-fat-diet fed Wistar rats
Lipids in Health and Disease (2016)
-
ROCK1 reduces mitochondrial content and irisin production in muscle suppressing adipocyte browning and impairing insulin sensitivity
Scientific Reports (2016)
-
Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
Endocrine (2016)
